✦ LIBER ✦

Design and Synthesis of Novel Epidermal Growth Factor Receptor Kinase Inhibitors.

✍ Scribed by Jae Du Ha; Seung Kyu Kang; Kun-Do Kim; Joong-Kwon Choi; Jae Yang Kong; Chang H. Ahn

Publisher: John Wiley and Sons
Year: 2005
Weight: 10 KB
Volume: 36
Category: Article
ISSN: 0931-7597
DOI: 10.1002/chin.200547217

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Salicylanilides as Inhibitors of the Pro

Salicylanilides as Inhibitors of the Protein Tyrosine Kinase Epidermal Growth Factor Receptor.

✍ Christoph Liechti; Urs Sequin; Guido Bold; Pascal Furet; Thomas Meyer; Peter Tra 📂 Article 📅 2004 🏛 John Wiley and Sons ⚖ 100 KB 👁 1 views

## Abstract For Abstract see ChemInform Abstract in Full Text.

Inhibitors of Epidermal Growth Factor Re

Inhibitors of Epidermal Growth Factor Receptor Tyrosine Kinase: Novel C-5 Substituted Anilinoquinazolines Designed to Target the Ribose Pocket.

✍ Jason G. Kettle; et al. et al. 📂 Article 📅 2006 🏛 John Wiley and Sons ⚖ 21 KB 👁 1 views

1,4-Dioxane-fused 4-anilinoquinazoline a

1,4-Dioxane-fused 4-anilinoquinazoline as inhibitors of epidermal growth factor receptor kinase

✍ Jae Yeol Lee; Yong Kyu Park; Seon Hee Seo; In-Seop So; Hee-Kyung Chung; Beom-Seo 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 43 KB 👁 1 views

ChemInform Abstract: 1,4-Dioxane-Fused 4

ChemInform Abstract: 1,4-Dioxane-Fused 4-Anilinoquinazoline as Inhibitors of Epidermal Growth Factor Receptor Kinase.

✍ Jae Yeol Lee; Yong Kyu Park; Seon Hee Seo; In-Seop So; Hee-Kyung Chung; Beom-Seo 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 30 KB 👁 2 views

Clinical implications of the mechanism o

Clinical implications of the mechanism of epidermal growth factor receptor inhibitors

✍ John Marshall 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 189 KB 👁 1 views

## Abstract Novel therapeutic agents that target the epidermal growth factor receptor (EGFR) constitute an important addition to the therapeutic armamentarium for the treatment of metastatic disease. EGFR‐targeted agents currently approved by the U.S. Food and Drug Administration include cetuximab,

Tricyclic Azepine Derivatives: Pyrimido[

Tricyclic Azepine Derivatives: Pyrimido[4,5-b]-1,4-benzoxazepines as a Novel Class of Epidermal Growth Factor Receptor Kinase Inhibitors.

✍ Evgueni L. Piatnitski; et al. et al. 📂 Article 📅 2006 🏛 John Wiley and Sons ⚖ 15 KB